Synonyms: AL 6802 | AL6802 | SIM 6802 | SIM6802
simotinib is an approved drug (China only)
Compound class:
Synthetic organic
Comment: Simotinib is an oral, epidermal growth factor receptor tyrosine kinase inhibitor [1]. It was developed by Jiangsu Simcere Pharmaceutical Research Company in Nanjing, China. See also patent WO2010021918A1. Simotinib treatment is associated with serious adverse effects on gastrointestinal physiology [2].
|
|
References |
1. He L, Li S, Xie F, Cheng Z, Ran L, Liu X, Yu P. (2014)
LC-ESI-MS/MS determination of simotinib, a novel epidermal growth factor receptor tyrosine kinase inhibitor: application to a pharmacokinetic study. J Chromatogr B Analyt Technol Biomed Life Sci, 947-948: 168-72. [PMID:24440798] |
2. Zhu Q, Liu Z, Li P, Cheng Z. (2014)
Drug interaction studies reveal that simotinib upregulates intestinal absorption by increasing the paracellular permeability of intestinal epithelial cells. Drug Metab Pharmacokinet, 29 (4): 317-24. [PMID:24522198] |